Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 23511-23520 Newer>

The Motley Fool May 25, 2007 Tom Taulli	STARLIMS' Dim Reception The laboratory software developer's growth prospects weren't enough for IPO investors.
The Motley Fool May 25, 2007 Mac Greer	Fool Video Take: Time to Buy Google? Is now the time to own a piece of the dominant search giant?
The Motley Fool May 25, 2007 Brian Lawler	BioMarin Waits for Another Drug BioMarin files a marketing application for its lead compound in development. Investors, take note.
The Motley Fool May 25, 2007 Rich Smith	American Superconductor's Vocab Lesson The firm teaches us a new way to fudge stock options. Investors, take note.
The Motley Fool May 25, 2007 Timothy M. Otte	Abercrombie Rides Out the Quarter The apparel retailer reports higher sales and profits but lower comps. The stock price has also been treading water since last fall, as investors try to figure out whether Abercrombie is out in front of their fickle customers, or is missing the wave.
BusinessWeek June 4, 2007 Gene G. Marcial	Amgen Believers There has been a deluge of bad news at biotech Amgen, whose stock has tumbled.
BusinessWeek June 4, 2007 Gene G. Marcial	What Big Investors See In Bioenvision Bioenvision has attracted big investors.
BusinessWeek June 4, 2007 Gene G. Marcial	Will Another Trucker Pick Up YRC? YRC is burdened with dismal earnings because of higher fuel costs and bad weather.
The Motley Fool May 24, 2007 Rich Smith	Palm Harbor Founders Reporting fiscal fourth-quarter and full-year 2006 earnings recently, the manufactured-home builder announced that quarterly sales slumped 25% year over year. Investors, things actually get worse.
The Motley Fool May 24, 2007 David Lee Smith	Foot Locker's Weak Kickoff With first-quarter earnings down 72%, the footwear retailer trims its upcoming guidance. Investors, take note.
<Older 23511-23520 Newer> Return to current articles.